Brand Name: EPIRUBICIN VIATRIS INJECTION, SOLUTION, CONCENTRATE PARENTERAL
Generic Name: EPIRUBICIN HYDROCHLORIDE INJECTION, SOLUTION, CONCENTRATE PARENTERAL
Indication: The therapeutic indications are limited to:
• breast carcinomas,
• ovarian cancers,
• malignant non-Hodgkin’s lymphomas, Hodgkin’s lymphoma,
• small-cell lung carcinomas
• soft tissue sarcomas,
• cancers of the esophagus, stomach and pancreas, hepatocellular cancers,
• squamous cell carcinoma of the head and neck
Dosage Forms:
- Epirubicin Vial 2mg/ml 5ml, 100mg/50ml
- Epirubicin Vial 2mg/1ml 25 ml, 50mg/25ml
Rout of Administration: Intravenous use
Storage: Store between +2°C and +8°C (in a refrigerator)
Manufacturer : Haupt Pharma Wolfratshausen
Country: France

